Balcinrenone/dapagliflozin clinical trials

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

This study looks at a new combination medicine for people with long-term kidney disease (CKD stages 3b and 4). It compares a new drug (balcinrenone/dapagliflozin) with an existing one (dapagliflozin) to see if it can slow down kidney disease and reduce heart problems, while being safe.